These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 24411698)

  • 21. Role of mismatch repair enzymes in GAA·TTC triplet-repeat expansion in Friedreich ataxia induced pluripotent stem cells.
    Du J; Campau E; Soragni E; Ku S; Puckett JW; Dervan PB; Gottesfeld JM
    J Biol Chem; 2012 Aug; 287(35):29861-72. PubMed ID: 22798143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frataxin gene point mutations in Italian Friedreich ataxia patients.
    Gellera C; Castellotti B; Mariotti C; Mineri R; Seveso V; Didonato S; Taroni F
    Neurogenetics; 2007 Nov; 8(4):289-99. PubMed ID: 17703324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FXN methylation predicts expression and clinical outcome in Friedreich ataxia.
    Evans-Galea MV; Carrodus N; Rowley SM; Corben LA; Tai G; Saffery R; Galati JC; Wong NC; Craig JM; Lynch DR; Regner SR; Brocht AF; Perlman SL; Bushara KO; Gomez CM; Wilmot GR; Li L; Varley E; Delatycki MB; Sarsero JP
    Ann Neurol; 2012 Apr; 71(4):487-97. PubMed ID: 22522441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxia.
    Greene E; Mahishi L; Entezam A; Kumari D; Usdin K
    Nucleic Acids Res; 2007; 35(10):3383-90. PubMed ID: 17478498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long intronic GAA*TTC repeats induce epigenetic changes and reporter gene silencing in a molecular model of Friedreich ataxia.
    Soragni E; Herman D; Dent SY; Gottesfeld JM; Wells RD; Napierala M
    Nucleic Acids Res; 2008 Nov; 36(19):6056-65. PubMed ID: 18820300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA methylation in Friedreich ataxia silences expression of frataxin isoform E.
    Rodden LN; Gilliam KM; Lam C; Rojsajjakul T; Mesaros C; Dionisi C; Pook M; Pandolfo M; Lynch DR; Blair IA; Bidichandani SI
    Sci Rep; 2022 Mar; 12(1):5031. PubMed ID: 35322126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in the determinants of right ventricular and regional left ventricular long-axis dysfunction in Friedreich ataxia.
    Peverill RE; Donelan L; Corben LA; Delatycki MB
    PLoS One; 2018; 13(12):e0209410. PubMed ID: 30596685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for chromosome fragility at the frataxin locus in Friedreich ataxia.
    Kumari D; Hayward B; Nakamura AJ; Bonner WM; Usdin K
    Mutat Res; 2015 Nov; 781():14-21. PubMed ID: 26379101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MutLα heterodimers modify the molecular phenotype of Friedreich ataxia.
    Ezzatizadeh V; Sandi C; Sandi M; Anjomani-Virmouni S; Al-Mahdawi S; Pook MA
    PLoS One; 2014; 9(6):e100523. PubMed ID: 24971578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Comprehensive Transcriptome Analysis Identifies FXN and BDNF as Novel Targets of miRNAs in Friedreich's Ataxia Patients.
    Misiorek JO; Schreiber AM; Urbanek-Trzeciak MO; Jazurek-Ciesiołka M; Hauser LA; Lynch DR; Napierala JS; Napierala M
    Mol Neurobiol; 2020 Jun; 57(6):2639-2653. PubMed ID: 32291635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small molecules affecting transcription in Friedreich ataxia.
    Gottesfeld JM
    Pharmacol Ther; 2007 Nov; 116(2):236-48. PubMed ID: 17826840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Friedreich's ataxia: new insights.
    Krasilnikova MM; Humphries CL; Shinsky EM
    Emerg Top Life Sci; 2023 Dec; 7(3):313-323. PubMed ID: 37698160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complete FXN deletion in a patient with Friedreich's ataxia.
    van den Ouweland AM; van Minkelen R; Bolman GM; Wouters CH; Becht-Noordermeer C; Deelen WH; Deelen-Manders JM; Ippel EP; Saris J; Halley DJ
    Genet Test Mol Biomarkers; 2012 Sep; 16(9):1015-8. PubMed ID: 22691228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GAA repeat polymorphism in Turkish Friedreich's ataxia patients.
    Yilmaz MB; Koç AF; Kasap H; Güzel AI; Sarica Y; Süleymanova D
    Int J Neurosci; 2006 May; 116(5):565-74. PubMed ID: 16644517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic promoter silencing in Friedreich ataxia is dependent on repeat length.
    Chutake YK; Lam C; Costello WN; Anderson M; Bidichandani SI
    Ann Neurol; 2014 Oct; 76(4):522-8. PubMed ID: 25112975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial damage and senescence phenotype of cells derived from a novel frataxin G127V point mutation mouse model of Friedreich's ataxia.
    Fil D; Chacko BK; Conley R; Ouyang X; Zhang J; Darley-Usmar VM; Zuberi AR; Lutz CM; Napierala M; Napierala JS
    Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32586831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Friedreich's ataxia with chorea and myoclonus caused by a compound heterozygosity for a novel deletion and the trinucleotide GAA expansion.
    Zhu D; Burke C; Leslie A; Nicholson GA
    Mov Disord; 2002 May; 17(3):585-9. PubMed ID: 12112211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exonic deletions of FXN and early-onset Friedreich ataxia.
    Anheim M; Mariani LL; Calvas P; Cheuret E; Zagnoli F; Odent S; Seguela C; Marelli C; Fritsch M; Delaunoy JP; Brice A; Dürr A; Koenig M
    Arch Neurol; 2012 Jul; 69(7):912-6. PubMed ID: 22409940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Friedreich's ataxia: past, present and future.
    Marmolino D
    Brain Res Rev; 2011 Jun; 67(1-2):311-30. PubMed ID: 21550666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Friedreich ataxia patient tissues exhibit increased 5-hydroxymethylcytosine modification and decreased CTCF binding at the FXN locus.
    Al-Mahdawi S; Sandi C; Mouro Pinto R; Pook MA
    PLoS One; 2013; 8(9):e74956. PubMed ID: 24023969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.